Category Archives: bodybuilding video


side effects of winstrol

When administered drug is well absorbed from the gastrointestinal tract (up to 95% of the dose), the use of food slows the absorption of fluoxetine significantly. Peak plasma concentrations are reached in 6-8 hours. The side effects of winstrol bioavailability after oral administration of fluoxetine is more than 60%. The drug was well accumulates in tissues readily penetrates the blood-brain barrier, binding to plasma proteins is above 90%. It is metabolized in the liver by demethylation to the active metabolite norfluoxetine and a number of unidentified metabolites. Report the news, the magnitude of the clearance of fluoxetine is 94-704 ml / min, norfluoxetine 60-336 ml / min. About 12% of the drug is released through the gastrointestinal tract. The half-life of fluoxetine is about 2-3 days, norfluoxetine – 7-9 days. In patients with hepatic failure half-lives of fluoxetine and norfluoxetine is prolonged. The drug is excreted in breast milk (25% of the serum concentration).



  • Depression different genesis.
  • Obsessive-Compulsive Disorder
  • Bulimic neurosis.

The drug is used strictly on prescription.


Hypersensitivity to the drug, simultaneous reception with inhibitors of monoamine oxidase (MAO), thioridazine and pimozide, severe renal dysfunction (creatinine clearance less than 10 ml / min) and liver, breastfeeding, pregnancy.

Precautions : diabetes, convulsions and epilepsy of various origins (including history), Parkinson’s disease, compensated renal and / or hepatic insufficiency, excessive weight loss, suicidal thoughts.

Dosing and Administration

The drug is taken orally.
In depression, obsessive disorders kompulsivnyh starting dose is 20 mg of fluoxetine per day (in the morning), regardless of the meal. If necessary, the dose may be increased to 40 – 60 mg / day, divided into 2-3 doses. The maximum daily dose is 80 mg. The clinical effect develops within 1-4 weeks after the start of treatment in some patients it can be achieved later.
In bulimia nervosa, the drug is used in a daily dose of 60 mg, divided into 2-3 receptions.
In elderly patients the recommended daily dose is 20 mg.
Patients renal and hepatic insufficiency, side effects of winstrol as well as with low body weight is recommended to use a lower dose -. 10 mg fluoxetine per day and lengthening the interval between receptions of
duration determined by the attending physician acceptance and can last for several years.

Side effect

CNS: hypomania or mania, increased suicidal tendencies, anxiety, irritability, agitation, dizziness, headache, tremor, insomnia or drowsiness, asthenic disorders, seizures. On the part of the gastrointestinal tract: loss of appetite, taste disturbance, nausea , vomiting, dry mouth or hypersalivation and diarrhea. With the genitourinary system: . incontinence or urinary retention, dysmenorrhea, vaginitis, decreased libido, sexual dysfunction in men (delayed ejaculation) are rare: allergic reactions such as skin rash, hives, itching , chills, fever, pain in muscles and joints (use of antihistamines and steroids); increased sweating, hyponatremia, tachycardia, disturbance of the visual acuity, erythema multiforme, vasculitis. May develop anorexia and weight loss. Such side effects frequently occur at the beginning or fluoxetine with increasing dose.


Symptoms: agitation, seizures, cardiac arrhythmia, tachycardia, nausea, vomiting. Treatment: specific antagonists to fluoxetine were found. Symptomatic therapy, gastric lavage with the appointment of activated charcoal, in convulsions – diazepam, maintenance of respiration, cardiac activity, body temperature.

Interaction with other drugs

The drug can not be applied simultaneously with  inhibitors (e.g., selegiline, furazolidone, procarbazine and the like), including antidepressants side effects of winstrol inhibitors; and tryptophan (a precursor of serotonin), pimozide, as may develop serotonin syndrome, which manifests itself in confusion, hypomania, agitation, convulsions, dysarthria, hypertensive crises, chills, tremor, nausea, vomiting, diarrhea (see. “Cautions “).
Co-administration of fluoxetine with alcohol or with centrally acting drugs that cause depression of the central nervous system, enhances their effect.
fluoxetine blocks the metabolism of tricyclic and tetracyclic antidepressants, trazodone, carbamazepine, diazepam, metoprolol, terfenadine, phenytoin (phenytoin), which leads to an increase in their concentration in the blood serum, reinforcing their action and increasing the incidence of complications.
The combined use of fluoxetine and lithium salts requires close monitoring of the concentration of lithium in the blood as possible its increase.
fluoxetine enhances the effect of hypoglycemic drugs.
in an application with drugs, possessing high protein binding, especially with anticoagulants and digitoxin, may increase the plasma concentration of free (unbound) drugs and increase the risk of adverse effects.

special instructions

Patients with diabetes may develop hypoglycemia during therapy with fluoxetine and hyperglycaemia after its cancellation.
On the background of electroconvulsive therapy may develop prolonged epileptic seizures.
After applying the appointment of  inhibitors fluoxetine may be no earlier than 14 days. Do not use  inhibitors and / or thioridazine earlier than 5 weeks after discontinuation of fluoxetine.
With the development, on a background of reception of fluoxetine, convulsions drug should be discontinued.
In the treatment of patients with deficiency of body weight should be considered anorectic effects (possible progressive loss of body weight ).
After discontinuation side effects of winstrol stanozolol of its therapeutic serum concentrations may persist for several weeks.
during treatment with fluoxetine intake of alcoholic beverages is not allowed.
fluoxetine may adversely affect the performance of work requiring a high rate of mental and physical reactions (drive motor vehicles, mechanisms, working at height, etc.).



Treatment should be continued until the replacement of the infected nail (uninfected nail sprouting). For the re-growth of nails on the fingers and feet normally requires 3-6 months. and 12.6 months, respectively. In deep endemic mycosis may require the use of the drug in a dose of 200 mg (4 capsules of 50 mg) – 400 mg (8 capsules 50 mg) per day for up to 2 years. The duration of therapy is determined individually; it can be 11-24 months. with coccidioidomycosis; 2-17 months. When stanozol paracoccidioidomycosis; 1-16 months. with sporotrichosis and 3-17 months. at histoplasmosis. In children, as well as with similar infections in adults, the duration of treatment depends on the clinical and mycological effect. In children, the drug should not be applied in a daily dose that would be higher than that in adult, i.e. no more than 400 mg per day. The drug is used every day 1 time per day.


Side effect From the digestive system: loss of appetite, changes in taste, nausea, vomiting, abdominal pain, flatulence, diarrhea, rarely – liver dysfunction (hyperbilirubinemia, increased alanine aminotransferase activity, aspartate aminotransferase, increased activity of alkaline phosphatase, jaundice, hepatitis, hepatocellular necrosis ). From the nervous system: headache, dizziness, excessive fatigue, rarely – seizures. From the side of hematopoiesis: rarely – leukopenia, thrombocytopenia (bleeding, petechiae), neutropenia, agranulocytosis. On the part of the cardiovascular system: an increase in the duration of the interval stanozol, flickering / ventricular flutter. Allergic reactions: skin rash, rarely – exudative erythema multiforme (including Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell’s syndrome), anaphylactoid reactions (including angioedema, facial swelling, hives, itching of the skin). Other: rarely – renal dysfunction, alopecia, hypercholesterolemia, hypertriglyceridemia, hypokalemia.

Overdose symptoms: hallucinations, paranoid behavior. Treatment is symptomatic: . Gastric lavage, forced diuresis Haemodialysis for 3 hours decreases the plasma concentration of approximately 50%.


Interaction with other drugs
When using fluconazole and warfarin increased the prothrombin time (an average of 12%). In this connection, it is recommended to closely monitor the performance of the prothrombin time in patients receiving the drug in combination with coumarin anticoagulants.
May increase the half-life of oral hypoglycemic agents – sulfonylureas (chlorpropamide, glibenclamide, glipizide, tolbutamide) while receiving fluconazole.
Concomitant use of fluconazole phenytoin and may lead to an increase in the plasma concentration of phenytoin to a clinically significant degree. Therefore, if necessary, the joint use of these drugs need to monitor the concentration of phenytoin with the dose adjusted to maintain drug levels within the therapeutic range.
Combination with rifampschinom stanozol leads to decrease by 25% and shorten the half-life of fluconazole from plasma by 20%. Therefore, patients receiving concomitant rifampicin, the dose of fluconazole is expedient to increase.
It is possible increase of cyclosporine concentrations with the simultaneous use of fluconazole 200 mg / day.
In the case of simultaneous reception with theophylline may reduce the average clearance of theophylline plasma velocity.
With the simultaneous use of fluconazole and cisapride concentration cisapride plasma can significantly increase; described cases of adverse reactions on the part of the heart, including . flicker / ventricular flutter including (torsades de points), an increase in the QT interval on the ECG
Simultaneous administration of azole antifungals and terfenadine may lead to a significant increase in the level of terfenadine in the plasma. may cause serious arrhythmias by increasing the  interval
Concomitant use of fluconazole and hydrochlorothiazide may lead to an increase of 40% in the plasma concentration of fluconazole.
There have been reports about the interaction of fluconazole and rifabutin, the latter accompanied by an increase in serum levels. With simultaneous use of fluconazole and rifabutin uveitis cases are described. We must carefully monitor patients while receiving rifabutan and fluconazole.
Patients receiving the combination of fluconazole and zidovudine, increasing the concentration of zidovudine observed, which is caused by a decrease in the conversion of the latter into its main metabolite, so you should expect an increase in the side effects of zidovudine.
Increasing the concentration of midazolam, in connection with the what increases the risk of psychomotor effects (more pronounced when using fluconazole inside than intravenously).
increasing the concentration of tacrolimus and therefore increases the risk of nephrotoxicity.

Specific guidance
Treatment should continue until clinical remission. Premature discontinuation of treatment leads to relapse.
In rare cases, the use of fluconazole was accompanied by toxic liver changes, including fatalities, primarily in patients with serious underlying medical conditions. In the case of hepatotoxic effects associated with fluconazole, no obvious dependence of the total daily dose, duration of treatment, gender, and age of the patient. Hepatotoxic effects of fluconazole was usually reversible; its signs disappeared after discontinuation of therapy. When clinical signs of liver damage, which may be associated with fluconazole, the drug should be discontinued.
AIDS patients are more prone to the development of severe skin reactions in the application of many drugs. In cases where patients with superficial fungal infection develops a rash, and she is regarded as definitely related to fluconazole, the drug should be discontinued. When a rash in patients with invasive / systemic fungal infections, they should be monitored closely and fluconazole cancel the appearance of bullous erythema multiforme or changes. Care must be taken while taking fluconazole with rifabutin or other drugs metabolized by the cytochrome stanozol system.
When combined fluconazole and oral hypoglycemic agents (chlorpropamide, glibenclamide, glipizide, tolbutamide) in patients with diabetes should monitor blood glucose levels (possibility of hypoglycemia). It is recommended to monitor blood concentration of cyclosporine while the use of fluconazole.
Patients who concurrently with fluconazole receiving high dose theophylline or who have a chance of developing theophylline intoxication dolzhnynahoditsya monitored for early detection of the symptoms of theophylline overdose.


stanozolol results

Hepatic and / or renal failure, rash during treatment with fluconazole in patients with superficial fungal infection and stanozolol results invasive / systemic fungal infections, concomitant use of terfenadine and fluconazole at a dose of less than 400 mg / day, simultaneous reception potentially hepatotoxic drugs, alcoholism potentially proaritmogennoe status in patients with multiple risk factors (organic heart disease, electrolyte disturbances, concomitant use of drugs that cause arrhythmias), pregnancy.

Pregnancy and lactation
Use of the drug in pregnant women – is impractical, except for serious or life-threatening forms of fungal infections, where the potential benefits from the use of fluconazole for the mother is much higher than the risk to the fetus. Since fluconazole concentration in breast milk and in the plasma of the same, use the drug during lactation is contraindicated.

Dosing and Administration
Inside, swallowing whole. Adults and children over 15 years (with a body weight over 50 kg) in cryptococcal meningitis and cryptococcal infections at other sites on the first day is usually prescribed 400 mg (8 capsules of 50 mg), and then continue treatment 200 mg (4 capsules of 50 mg) – 400 mg (8 capsules of 50 mg), 1 time per day. The duration of treatment for cryptococcal infections depends on the clinical efficacy, confirmed by mycological examination; cryptococcal meningitis treatment should be at least 6-8 weeks. For the prevention of recurrence of cryptococcal meningitis in  patients, after completion of a full course of primary therapy fluconazole administered in a dose of 200 mg (4 capsules of 50 mg) per day for a long period of time. when candidemia, disseminated candidiasis, Candida and other invasive infections in the first day dose was 400 mg (8 capsules of 50 mg), and then – 200 mg (4 capsules of 50 mg) per day.

When insufficient clinical efficacy of the dose can be increased to 400 mg (8 capsules 50 mg) per day. The duration of therapy depends on clinical efficacy. In oropharyngeal candidiasis drug is usually prescribed at 150 mg 1 times / day; Duration of treatment – 7-14 days. If necessary, in patients with a severely reduced immune treatment may be longer. For the prevention of relapse of oropharyngeal candidiasis in patients with AIDS, after the completion of a full course of primary therapy – 150 mg 1 time per week. In atrophic oral candidiasis associated with stanozolol results wearing dentures, – 50 mg 1 time per day for 14 days in combination with local antiseptic drugs for the treatment of the prosthesis. in other localizations candidiasis (except genital candidiasis), such as esophagitis, noninvasive bronchopulmonary defeat candiduria candidiasis of the skin and mucous membranes, etc. .d., the effective dose is usually 150 mg / day when the duration of treatment 14-30 days. vaginal candidiasis fluconazole receive a single oral dose of 150 mg. To reduce the frequency of relapses vaginal candidiasis drug may be used in a dose of 150 mg 1 time per month.

The duration of therapy is determined individually; it varies between 4 and 12 months. Some patients may require more frequent application. When balanitis caused of Candida, fluconazole administered single oral dose of 150 mg per day. For the prevention of candidiasis recommended dose – 50-400 mg 1 time per day, depending on the degree of risk of fungal infection. To prevent candidiasis in patients with cancer the recommended dose of fluconazole is 150-400 mg 1 time / day, depending on the degree of risk of fungal infection. If you have a high risk of generalized infection, eg in patients with severe or long-anticipated persistent neutropenia, the recommended dose – 400 mg / day. Fluconazole is administered a few days before the expected occurrence of neutropenia; after increasing the number of neutrophils over one thousand / ml treatment continued for 7 days. At mycosis of the skin, including tinea pedis, smooth skin, inguinal, and skin candidosisrecommended dose stanozolol results is 150 mg 1 time per week or 50 mg 1 time per day , the dosage regimen depends on the clinical and mycological effect. Duration of therapy in ordinary cases is 2-4 weeks, but with athlete’s foot may require a more prolonged treatment (up to 6 weeks). When pityriasis versicolor – 300 mg (two 150 mg capsules) 1 time per week for 2 weeks, some patients It required a third dose of 300 mg per week, while in some cases it is sufficient single dose of 300-400 mg; alternative treatment is the use of 50 mg 1 time a day for 2-4 weeks. In onychomycosis the recommended dose is 150 mg 1 time per week.